Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system

Human Reproduction

Volumn 21, Issue 5, 2006, Pages 1129-1134

  Peloggia, Alessandra ^a   Petta, Carlos A ^a   Bahamondes, Luis ^a   Oliveira Ribeiro, Marilia ^a   Zhang, Jin ^b   Salamonsen, Lois ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Chemokines; Leucocytes; LNG IUS; Mast cells

Indexed keywords

ANTIBODY; CHEMOKINE; INTERLEUKIN 8; LEVONORGESTREL; TRYPTASE;

AMENORRHEA; ARTICLE; BREAKTHROUGH BLEEDING; CELL ASSAY; CELL COUNT; CONTROLLED STUDY; ENDOMETRIUM; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE CONTRACEPTIVE DEVICE; LEUKOCYTE; LONG TERM CARE; MAST CELL; MENSTRUAL CYCLE; NATURAL KILLER CELL; NEUTROPHIL; STATISTICAL ANALYSIS; STROMA;

EID: 33645819178     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei476     Document Type: Article

References (39)

1. Andersson K and Rybo G (1990) Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 97,690-694.
2. Andersson K, Mattsson LA, Rybo G and Stadberg E (1992) Intrauterine release of levonorgestrel - a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 79,963-967.
3. Barbosa I, Olsson SE, Odlind V, Gonçalves T and Coutinho E (1995) Ovarian function after a seven years' use of a levonorgestrel IUD. Adv Contracept 11,85-95.
4. Bulmer JN, Luny DP and Hagin SV (1988) Immunohistochemical characterization of stromal leukocytes in nonpregnant human endometrium. Am J Reprod Immunol 17,83-90.
5. Bulmer JN, Longfellow M and Ritson A (1991) Leukocytes and resident blood cells in endometrium. Ann N Y Acad Sci 622,57-68.
6. Clark DA, Wang SL, Rogers P, Vince G and Affandi B (1996) Endometrial lymphomyeloid cells in abnormal bleeding due to levonorgestrel (Norplant). Hum Reprod 11,1438-1444.
7. Critchley HO, Wang H, Jones RL, Kelly RW, Drudy TA, Gebbie AE, Buckley CH, McNeilly AS and Glasier AF (1998) Morphological and functional features of endometrial decidualization following long term intrauterine levonorgestrel delivery. Hum Reprod 13,1218-1224.
8. Drudy L, Sheppard B and Bonnar J (1991) Mast cells in the normal uterus and in dysfunctional uterine bleeding. Eur J Obstet Gynecol Reprod Biol 39,193-201.
9. Hickey M, Dwarte D and Fraser IS (2000) Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 15,1509-1514.
10. Hickey M, Crewe J, Goodridge JP, Witt CS, Fraser IS, Doherty D, Christiansen FT and Salamonsen LA (2005) Menopausal hormone therapy and irregular endometrial bleeding: A potential role for uterine natural killer cells? J Clin Endocrinol Metab 90,5528-5535.
11. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, Kujansuu E, Vuorma S, Yliskoski M and Paavonen J (2004) Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA 291,1456-1463.
12. Jeziorska M, Salamonsen LA and Woolley DE (1995) Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 53,312-320.
13. Jones RL, Kelly RW and Critchley HO (1997) Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation. Hum Reprod 12,1300-1306.
14. Jones RL, Hannan NJ, Kaituú TJ, Zhang J and Salamonsen LA (2004) Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 89,6155-6167.
15. Jones RL, Morison NB, Hannan NJ, Critchley HOD and Salamonsen LA (2005) Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations. Hum Reprod 20,2724-2735.
16. Kamat BR and Isaacson PG (1987) The immunocytochemical distribution of leukocyte subpopulations in human endometrium. Am J Pathol 127,66-73.
17. Lockhat FB, Emembolu JO and Komje JC (2005) The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (Levonorgestrel): A 3 year follow-up. Hum Reprod 20,789-793. and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (Levonorgestrel): A 3 year follow-up. Hum Reprod 20,789-793.
18. Lockwood CJ, Runic R, Wan L, Krikun G, Demopolous R and Schatz F (2000) The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception. Hum Reprod 15 (Suppl. 3),144-151.
19. Luukkainen T, Lähteenmäki P and Toivonen J (1990) Levonorgestrel-releasing intrauterine device. Ann Med 22,85-90.
20. Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2,656-663.
21. Monteiro I, Bahamondes L, Diaz J, Perrotti M and Petta C (2002) Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: A pilot study. Contraception 65,325-328.
22. Nilsson CJ, Luukkainen T and Arko H (1978) Endometrial morphology of women using a D-norgestrel-releasing intrauterine device. Fertil Steril 29,397-401.
23. Nilsson G, Haukkamaa M, Vierola H and Luukkainen T (1982) Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol (Oxf) 17,529-536.
24. Noyes RN, Hertig AT and Rock J (1950) Dating the endometrial biopsy. Fertil Steril 1,3-25.
25. Odlind V (1998) Disturbances of bleeding with intrauterine contraceptive devices and hormonal intrauterine systems. In Cameron IT, Fraser IS and Smith SK (eds) Clinical Disorders of the Endometrium and Menstrual Cycle. Oxford University Press, Oxford, UK, pp. 390-398.
26. Odlind V and Fraser IS (1990) Hormonal contraception and bleeding disturbances: A clinical overview. In d'Arcangues C, Fraser IS, Newton JR and Odlind V (eds). Contraception and Mechanism of Endometrial Bleeding. WHO/Cambridge University Press, Cambridge, pp. 5-31.
27. Oliveira-Ribeiro M, Petta CA, De Angelo Andrade LA, Bahamondes L and Hidalgo MM (2004) Correlation between endometrial histology, microvascular density and caliber, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel releasing intrauterine system. Hum Reprod 19,1778-1784.
28. Pekonen F, Nyman T, Lahteenmaki P, Haukkamaa M and Rutanen EM (1992) Intrauterine progestin induces continuous insulin-like growth factor-binding protein production in the human endometrium. J Clin Endocrinol Metab 75,660-664.
29. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa e Silva JC, Podagaec S and Bahamondes L (2005) Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 20,1993-1998.
30. Poropatich C, Rojas M and Silverberg SG (1987) Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle. Int J Gynaecol Pathol 6,230-234.
31. Salamonsen LA (1998) Current concepts of the mechanisms of menstruation: a normal process of tissue destruction. Trends Endocrinol Metab 9,305-309.
32. Salamonsen LA and Lathbury LJ (2000) Endometrial leukocytes and menstruation. Hum Reprod Update 6,16-27.
33. Song JY, Russell P, Markham R, Manconi F and Fraser IS (1996) Effects of high dose progestogens on white cells and necrosis in human endometrium. Hum Reprod 11,1713-1718.
34. Suhonen SP, Holmstrom T, Allonen HO and Lahteenmaki P (1995) Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy. Fertil Steril 63,336-342.
35. Toivonen J, Luukkainen T and Allonen H (1991) Protective effect of intrauterine release of levonorgestrel on pelvic infection: Three years' comparative experience of levonorgestrel - and cooper-releasing intrauterine devices. Obstet Gynecol 77,261-264.
36. Trundley A and Moffett A (2004) Human uterine leukocytes and pregnancy. Tissue Antigens 63,1-12.
37. Vincent AJ and Salamonsen LA (2000) The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 15 (Suppl. 3),135-143.
38. Vincent AJ, Malakooti N, Zhang J, Rogers PA, Affandi B and Salamonsen LA (1999) Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B). Hum Reprod 14,807-815.
39. Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G and Salamonsen LA (2000) Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives. Hum Reprod 15,123-130.